ATP4A gene regulatory network for fine-tuning of proton pump and ion channels

The ATP4A encodes α subunit of H + , K + -ATPase that contains catalytic sites of the enzyme forming pores through cell membrane which allows the ion transport. H + , K + -ATPase is a membrane bound P-type ATPase enzyme which is found on the surface of parietal cells and uses the energy derived from...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Systems and synthetic biology 2013-06, Vol.7 (1-2), p.23-32
Hauptverfasser: Singh, Vijai, Mani, Indra, Chaudhary, Dharmendra Kumar
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:The ATP4A encodes α subunit of H + , K + -ATPase that contains catalytic sites of the enzyme forming pores through cell membrane which allows the ion transport. H + , K + -ATPase is a membrane bound P-type ATPase enzyme which is found on the surface of parietal cells and uses the energy derived from each cycle of ATP hydrolysis that can help in exchanging ions (H + , K + and Cl − ) across the cell membrane secreting acid into the gastric lumen. The 3-D model of α-subunit of H + , K + -ATPase was generated by homology modeling. It was evaluated and validated on the basis of free energies and amino acid residues. The inhibitor binding amino acid active pockets were identified in the 3-D model by molecular docking. The two drugs Omeprazole and Rabeprazole were found more potent interactions with generated model of α-subunit of H + , K + -ATPase on the basis of their affinity between drug–protein interactions. We have generated ATP4A gene regulatory networks for interactions with other proteins which involved in regulation that can help in fine-tuning of proton pump and ion channels. These findings provide a new dimension for discovery and development of proton pump inhibitors and gene regulation of the ATPase. It can be helpful in better understanding of human physiology and also using synthetic biology strategy for reprogramming of parietal cells for control of gastric ulcers.
ISSN:1872-5325
1872-5333
DOI:10.1007/s11693-012-9103-1